Unichem Laboratories Ltd (UNICHEMLAB) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

SMS Pharma.

IOL Chemicals

RPG LifeScience.

Unichem Labs.

Advanced Enzyme

Morepen Labs.

Gufic BioScience

Dishman Carbogen

Indoco Remedies

Hikal

Panacea Biotec

Why is Unichem Laboratories Ltd ?

Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.87 times

Poor long term growth as Net Sales has grown by an annual rate of 12.60% over the last 5 years
Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.87 times
The company has been able to generate a Return on Equity (avg) of 1.44% signifying low profitability per unit of shareholders funds

The company declared negative results in Dec'25 after flat results in Sep'25

PAT(Q) At Rs -11.23 cr has Fallen at -130.6% (vs previous 4Q average)
INTEREST(Latest six months) At Rs 15.66 cr has Grown at 30.50%
OPERATING PROFIT TO INTEREST (Q) Lowest at 0.00 times

Below par performance in long term as well as near term

Along with generating -44.99% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Unichem Labs. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Unichem Labs.

-45.68%

-1.19

37.72%

Sensex

7.07%

0.61

11.53%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.60%

EBIT Growth (5y)

37.55%

EBIT to Interest (avg)

-1.70

Debt to EBITDA (avg)

4.66

Net Debt to Equity (avg)

0.13

Sales to Capital Employed (avg)

0.57

Tax Ratio

11.37%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

11.73%

ROCE (avg)

-0.39%

ROE (avg)

1.44%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.22

EV to EBIT

24.45

EV to EBITDA

12.74

EV to Capital Employed

1.20

EV to Sales

1.48

PEG Ratio

0.05

Dividend Yield

ROCE (Latest)

4.90%

ROE (Latest)

6.03%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

ROCE(HY)

Highest at 6.30%

EPS(Q)

Highest at Rs 37.54

-18What is not working for the Company

PBT LESS OI(Q)

At Rs 6.11 cr has Fallen at -77.2% (vs previous 4Q average

PAT(Q)

At Rs 16.13 cr has Fallen at -56.0% (vs previous 4Q average

INTEREST(Latest six months)

At Rs 15.66 cr has Grown at 30.50%

DEBT-EQUITY RATIO(HY)

Highest at 0.21 times

NET SALES(Q)

Lowest at Rs 521.17 cr

NON-OPERATING INCOME(Q)

is 65.88 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Unichem Labs.

Earnings per Share (EPS) - Quarterly

Highest at Rs 37.54

in the last five quarters

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Unichem Labs.

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 6.11 cr has Fallen at -77.2% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs 26.85 Cr

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 16.13 cr has Fallen at -56.0% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 36.68 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Latest six months

At Rs 15.66 cr has Grown at 30.50%

over previous Half yearly period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Net Sales - Quarterly

Lowest at Rs 521.17 cr

in the last five quarters

MOJO Watch

Near term sales trend is negative

Net Sales (Rs Cr)

Net Sales - Quarterly

At Rs 521.17 cr has Fallen at -6.3% (vs previous 4Q average)

over average Net Sales of the previous four quarters of Rs 556.46 Cr

MOJO Watch

Near term sales trend is negative

Net Sales (Rs Cr)

Non Operating Income - Quarterly

is 65.88 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Debt-Equity Ratio - Half Yearly

Highest at 0.21 times

in the last five half yearly periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio